• 1
    Bugalho A, Bique C, Almeida L, Bergstrom S. Application of vaginal misoprostol before cervical dilatation to facilitate first-trimester pregnancy interruption. Obstet Gynecol 1994;83: 729731.
  • 2
    Bugalho A, Bique C, Pereira C, Granja AC, Bergstrom S. Uterine evacuation by vaginal misoprostol after second trimester pregnancy interruption. Acta Obstet Gynecol Scand 1996;75: 270273.
  • 3
    El-Refaey H, Calder L, Wheatley DN, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994;343: 12071209.
  • 4
    Hofmeyr GJ, Gulmecoglu AM. Vaginal misoprostol for cervical ripening and labour induction in late pregnancy. Cochrane Database of Systematic Reviews, Version 2, CD 000941, 2000.
  • 5
    Ngai SW, Chan YM, Liu KL, Ho PC. Oral misoprostol for cervical priming in nonpregnant women. Hum Reprod 1997;12: 23732375.
  • 6
    Ngai SW, Chan YM, Ho PC. The use of misoprostol prior to hysteroscopy in postmenopausal women. Hum Reprod 2001;16: 14861488.
  • 7
    Preutthipan S, Herabutya Y. A randomised controlled trial of vaginal misoprostol for cervical priming before hysteroscopy. Obstet Gynecol 1999;94: 427430.
  • 8
    Ding JQ, Granberg S, Norstrom A. Clinical effects and cervical tissue changes after treatment with 16,16 dimethyl-trans delta 2 PGE1 methylester in the first trimester. Prostaglandins 1990;39: 281285.
  • 9
    Rabe T, Willinger G, Kiesel L, et al. Study of 16,16′-dimethyl-trans-delta 2 prostaglandin E1 methyl ester vaginal suppository for cervical dilatation in premenopausal and postmenopausal women. Advan Contracep 1985;1: 91102.
  • 10
    Hald F, Kristoffersen SE, Gregersen E. Prostaglandin vaginal suppositories in non pregnant women requiring cervical dilatation prior to hysteroscopy. Acta Obstet Gynecol Scand 1988;67: 219222.